Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
7.DunlapH.F.,LemonW.S.:Thehereditarytypeofangioneuroticedema.AmericanJournalof
MedicalScience.1929;177:259-273.
8.CockayneE.A.:Inheritedabnormalitiesoftheskinanditsappendages.OxfordUniversityPress,
Oxford1933:371-375.
9.PenskyJ.,LevyL.R.,LepowI.H.:PartialpurificationofaseruminhibitorC1-esterase.Journal
ofBiologicalChemistry.1961;236:1674-1679.
10.LandermanN.:Hereditaryangioneuroticedema:I.Casereportsandreviewoftheliterature.
JournalofAllergy.1962;33:316-329.
11.DonaldsonV.H.,EvansR.R.:Abiochemicalabnormalityinhereditaryangioneuroticedema:
absenceofseruminhibitorC1-esterase.AmericanJournalofMedicine.1963;35:37-44.
12.DonaldsonV.H.,RosenF.S.:Actionofcomplementinhereditaryangioneuroticedema:therole
ofinhibitorC1-esterase.JournalofClinicalInvestigation.1964;43:2204-2213.
13.RosenF.S.,PenskyJ.,DonaldsonV.H.iwsp.:Hereditaryangioneuroticedema:twogenetic
variants.Science.1965;148:957-958.
14.RosenF.S.,AlperC.A.,PenskyJ.iwsp.:GeneticallydeterminedheterogeneityoftheC1esterase
inhibitorinpatientswithhereditaryangioneuroticedema.JournalofClinicalInvestigation.1971;
50:2143-2149.
15.CaldwellJ.R.,RuddyS.,SchurP.H.iwsp.:AcquiredC1-inhibitordeficiencyinlymphosarcoma.
ClinicalImmunologyandImmunopathology.1972;1:39-52.
16.FieldsT.,GhebrehiwetB.,KaplanA.P.:Kininformationinhereditaryangioedemaplasma:
evidenceagainstkininderivationfromC2andinsupportof“spontaneous”formationofbradykinin.
JournalofAllergyandClinicalImmunology.1983;72:54-60.
17.GehaR.S.,QuintiI.,AustenK.F.iwsp.:AcquiredC1-inhibitordeficiencyassociatedwith
antiidiotypicantibodytomonoclonalimmunoglobulins.NewEnglandJournalofMedicine.
1985;312:534-540.
18.AlsenzJ.,BorkK.,LoosM.:Autoantibody-mediatedacquireddeficiencyofC1inhibitor.New
EnglandJournalofMedicine.1987;316:1360-1366.
19.JettG.K.:Captopril-inducedangioedema.AnnalsofEmergencyMedicine.1984;13:489-490.
20.IsrailiZ.H.,HallD.:Coughandangioneuroticedemaassociatedwithangiotensinconverting-enzyme
inhibitortherapy.AnnalsofInternalMedicine.1992;117:234-243.
21.NussbergerJ.,CugnoM.,AmstutzC.iwsp.:Plasmabradykinininangio-oedema.Lancet.
1998;351:1693-1697.
22.BorkK.,BarnstedtS.,KochP.iwsp.:HereditaryangioedemawithnormalC1-inhibitoractivity
inwomen.Lancet.2000;356:213-217.
23.CichonS.,MartinL.,HenniesH.iwsp.:IncreasedactivityofcoagulationfactorXII(Hageman
factor)causeshereditaryangioedematypeIII.AmericanJournalofHumanGenetics.2006;
79:1098-1104.
24.BorkK.,WulffK.,WitzkeG.iwsp.:HereditaryangioedemawithnormalC1-INHwithversus
withoutspecificFXIIgenemutations.Allergy.2015;70:1004-1012.
25.BorkK.,WulffK.,Steinmuller-MaginL.iwsp.:Hereditaryangioedemawithamutationinthe
plasminogengene.Allergy.2018;73:442-450.
26.GermenisA.E.,MargaglioneM.,PesqueroJ.iwsp.:Internationalconsensusontheuse
ofgeneticsinthemanagementofhereditaryangioedema.JournalofAllergyandClinicalImmuno-
logy:InPractice.2019.
